Wiącek Marcin, Szymański Maciej, Walewska Klaudia, Bartosik-Psujek Halina
Institute of Medical Sciences, University of Rzeszow, Rzeszów, Poland.
Front Neurol. 2022 Jul 5;13:884519. doi: 10.3389/fneur.2022.884519. eCollection 2022.
Symptomatic intracranial hemorrhage (sICH) and malignant brain edema (MBE) are well-known deleterious endovascular treatment (EVT) complications that some studies found to be associated with postprocedural blood pressure (BP) variability. We aimed to evaluate their association with periprocedural BP changes, including its intraprocedural decrease.
We retrospectively analyzed the data of 132 consecutive patients that underwent EVT between 1 December 2018 and 31 December 2019, for anterior circulation ischemic stroke. Analyzed predictors of sICH and MBE included non-invasively obtained BP before and 5-min after treatment, intraprocedural relative decreases of BP from baseline, and its post-treatment increases. SICH was defined in accordance with the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) criteria and MBE as brain edema with midline shift on the follow-up imaging. We used binary logistic regression analysis to investigate the association of BP parameters and the incidence of sICH and MBE.
Among the included patients, 11 (8.3%) developed sICH and 31 (23.5%) MBE. The intraprocedural decrease of mean arterial blood pressure (MAP) was independently associated with MBE occurrence (aOR per 10 mmHg drop from baseline 1.27; 95% CI 1.01-1.60; P = 0.040). Over 40% MAP drop was associated with a higher risk of sICH in the entire cohort (aOR 4.24; 95% CI 1.33-13.51; P = 0.015), but not in the subgroup with successful reperfusion (aOR 2.81; 95% CI 0.64-12.23; P = 0.169). Post-treatment systolic blood pressure (SBP) and MAP elevation above their minimal values during MT are significantly associated with the development of sICH (aOR per 10 mmHg SBP increase 1.78; 95% CI 1.15-2.76; P = 0.010 and aOR per 10 mmHg MAP increase 1.78; 95% CI 1.04-3.03; P = 0.035).
In the anterior circulation ischemic stroke patients relative MAP decrease during EVT is associated with a higher risk of MBE occurrence, and over 40% MAP drop with a higher incidence of both MBE and sICH. Post-treatment elevation of SBP and MAP increased the risk of sICH.
症状性颅内出血(sICH)和恶性脑水肿(MBE)是众所周知的有害血管内治疗(EVT)并发症,一些研究发现它们与术后血压(BP)变异性有关。我们旨在评估它们与围手术期血压变化的关联,包括术中血压下降。
我们回顾性分析了2018年12月1日至2019年12月31日期间连续接受EVT治疗的132例前循环缺血性卒中患者的数据。分析的sICH和MBE预测因素包括治疗前和治疗后5分钟无创获得的血压、术中血压相对于基线的下降以及治疗后血压的升高。sICH根据卒中溶栓安全实施监测研究(SITS-MOST)标准定义,MBE定义为随访影像上有中线移位的脑水肿。我们使用二元逻辑回归分析来研究血压参数与sICH和MBE发生率之间的关联。
在纳入的患者中,11例(8.3%)发生了sICH,31例(23.5%)发生了MBE。术中平均动脉压(MAP)下降与MBE的发生独立相关(每从基线下降10 mmHg的调整后比值比为1.27;95%可信区间为1.01-1.60;P = 0.040)。在整个队列中,MAP下降超过40%与sICH风险较高相关(调整后比值比为4.24;95%可信区间为1.33-13.51;P = 0.015),但在再灌注成功的亚组中并非如此(调整后比值比为2.81;95%可信区间为0.64-12.23;P = 0.169)。治疗后收缩压(SBP)和MAP高于MT期间的最低值与sICH的发生显著相关(SBP每升高10 mmHg的调整后比值比为1.78;95%可信区间为1.15-2.76;P = 0.010,MAP每升高10 mmHg的调整后比值比为1.78;95%可信区间为1.04-3.03;P = 0.035)。
在前循环缺血性卒中患者中,EVT期间MAP相对下降与MBE发生风险较高相关,MAP下降超过40%时MBE和sICH的发生率均较高。治疗后SBP和MAP升高增加了sICH的风险。